https://www.indianpharmapost.com/cdsco-expert-committee-recommends-emergency-use-authorisation-to-covovax-and-corbevax-109342021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/aurobindo-to-manufacture-and-market-molnupiravir-109462021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-receives-emergency-use-authorisation-for-molnupiravir-109452021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/strides-to-market-molnupiravir-under-the-brand-name-stripiravir-109442021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/torrent-pharma-to-launch-molnupiravir-under-the-brand-name-molnutor-in-india-109432021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/natco-receives-approval-for-the-drug-for-the-treatment-of-covid-19-109422021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/indias-1st-indigenously-developed-protein-sub-unit-covid-19-vaccine-corbevax-gets-nod-109412021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/sun-pharma-receives-dcgi-approval-for-molxvir-in-india-109402021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/cipla-receives-eua-for-cipmolnu-109392021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/trastuzumab-deruxtecan-type-ii-variation-application-validated-by-ema-109382021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/granules-inc-receives-anda-approval-for-prazosin-hydrochloride-109372021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/expectations-and-predictions-for-2022-109362021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/raphacure-partners-with-zeebon-for-foraying-into-north-east-market-109352021-12-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/optimus-pharma-to-manufacture-and-market-molnupiravir-109472021-12-28T00:00:00+05:30always0.9